Literature DB >> 15891184

MR imaging of salivary duct carcinoma.

Ken Motoori1, Yumiko Iida, Yuichirou Nagai, Seiji Yamamoto, Takuya Ueda, Hiroyuki Funatsu, Hisao Ito, Okamoto Yoshitaka.   

Abstract

BACKGROUND AND
PURPOSE: Salivary duct carcinoma (SDC) is regarded as a high-grade malignancy in the current classification of salivary gland neoplasms. The aim of our study was to describe the MR imaging features of SDC.
METHODS: Nine patients with SDC underwent MR imaging study. The apparent diffusion coefficient (ADC) values of SDCs were measured from diffusion-weighted images. Time-signal intensity curves (TICs) of the tumors on dynamic MR images were plotted, and washout ratios were also calculated. TICs were divided into four types: type A, curve peaks <120 seconds after administration of contrast material with high washout ratio (> or =30%); type B, curve peaks <120 seconds with low washout ratio (<30%); type C, curve peaks >120 seconds; type D, nonenhanced. We correlated the MR findings of SDC with the pathologic findings.
RESULTS: All tumors had ill-defined margins and showed low to moderately high signal intensity for contralateral parotid gland on T2-weighted images. The average of the ADC values of the SDCs was 1.16 +/- 0.14 [SD] x 10(-3)mm(2)/s. Seven of nine (78%) tumors had type B enhancement. On the other hand, six of nine (67%) tumors with rich fibrotic tissue also had type C enhancement.
CONCLUSION: The findings of ill-defined margin, early enhancement with low washout ratio (type B), and low ADC value (1.22 x 10(-3)mm(2)/s) were useful for suggesting malignant salivary gland tumors. Although it was reported that type C enhancement was specific for pleomorphic adenoma, SDC frequently has type C-enhanced focus.

Entities:  

Mesh:

Year:  2005        PMID: 15891184      PMCID: PMC8158590     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  20 in total

Review 1.  Salivary duct carcinoma: clinical characteristics and treatment strategies.

Authors:  M Guzzo; S Di Palma; C Grandi; R Molinari
Journal:  Head Neck       Date:  1997-03       Impact factor: 3.147

2.  Infiltrating salivary duct carcinoma. A clinicopathologic study of five cases.

Authors:  K T Chen; G R Hafez
Journal:  Arch Otolaryngol       Date:  1981-01

3.  Salivary duct carcinoma--a clinicopathologic study of 12 cases.

Authors:  L E Afzelius; W R Cameron; C Svensson
Journal:  Head Neck Surg       Date:  1987 Jan-Feb

4.  Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging.

Authors:  J Wang; S Takashima; F Takayama; S Kawakami; A Saito; T Matsushita; M Momose; T Ishiyama
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

5.  Salivary duct carcinoma (cribriform salivary carcinoma of excretory ducts). A clinicopathologic and immunohistochemical study of 12 cases.

Authors:  M S Brandwein; J Jagirdar; J Patil; H Biller; M Kaneko
Journal:  Cancer       Date:  1990-05-15       Impact factor: 6.860

6.  Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.

Authors:  L D Buadu; J Murakami; S Murayama; N Hashiguchi; S Sakai; K Masuda; S Toyoshima; S Kuroki; S Ohno
Journal:  Radiology       Date:  1996-09       Impact factor: 11.105

7.  Salivary duct carcinoma.

Authors:  R Delgado; F Vuitch; J Albores-Saavedra
Journal:  Cancer       Date:  1993-09-01       Impact factor: 6.860

8.  Salivary duct carcinoma: an analysis of four cases with review of literature.

Authors:  T A Garland; D J Innes; R E Fechner
Journal:  Am J Clin Pathol       Date:  1984-04       Impact factor: 2.493

9.  Characteristic bright signal of parotid pleomorphic adenomas on T2-weighted MR images with pathological correlation.

Authors:  Y Tsushima; M Matsumoto; K Endo; T Aihara; T Nakajima
Journal:  Clin Radiol       Date:  1994-07       Impact factor: 2.350

10.  Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation.

Authors:  Hidetake Yabuuchi; Tatsuro Fukuya; Tsuyoshi Tajima; Yoichi Hachitanda; Kichinobu Tomita; Mitsuru Koga
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

View more
  16 in total

1.  Salivary duct carcinomas: clinical and CT and MR imaging features in 20 patients.

Authors:  Young Cheol Weon; Sun-Won Park; Hyung-Jin Kim; Han-Sin Jeong; Young-Hyeh Ko; In Suh Park; Sung Tae Kim; Chung Hwan Baek; Young-Ik Son
Journal:  Neuroradiology       Date:  2012-02-04       Impact factor: 2.804

2.  Diagnosing common parotid tumours with magnetic resonance imaging including diffusion-weighted imaging vs fine-needle aspiration cytology: a comparative study.

Authors:  H Yerli; E Aydin; N Haberal; A Harman; T Kaskati; S Alibek
Journal:  Dentomaxillofac Radiol       Date:  2010-09       Impact factor: 2.419

3.  Epithelial-myoepithelial carcinoma of the parotid gland: correlation of dynamic magnetic resonance imaging, (18)F-fluorodeoxyglucose-positron emission tomography, and pathological findings.

Authors:  Koji Takumi; Yoshihiko Fukukura; Takuro Kamiyama; Masayuki Nakajo; Junichiro Ohori; Yuichi Kurono; Michiyo Higashi
Journal:  Jpn J Radiol       Date:  2010-10-24       Impact factor: 2.374

4.  Salivary duct carcinoma of the extra-glandular segment of Stensen's duct: radiological findings and pathological correlation (2008: 10b).

Authors:  Fumito Okada; Koichi Honda; Yumiko Ando; Tomoko Nakayama; Michiaki Sai; Shuichi Tanoue; Shunro Matsumoto; Hiromu Mori
Journal:  Eur Radiol       Date:  2009-01-19       Impact factor: 5.315

5.  Head and neck MRI of Kimura disease.

Authors:  T Horikoshi; K Motoori; T Ueda; R Shimofusa; T Hanazawa; Y Okamoto; H Ito
Journal:  Br J Radiol       Date:  2011-09       Impact factor: 3.039

6.  Salivary Duct Carcinoma of Parotid Gland: a Rare Tumor.

Authors:  Giridhar Chidananda-Murthy; Jayanthi Chandran
Journal:  Indian J Surg Oncol       Date:  2018-12-12

7.  The diagnostic value of combining conventional, diffusion-weighted imaging and dynamic contrast-enhanced MRI for salivary gland tumors.

Authors:  Ning Zheng; Rui Li; Wenjuan Liu; Shuo Shao; Shan Jiang
Journal:  Br J Radiol       Date:  2018-06-27       Impact factor: 3.039

8.  Apparent diffusion coefficient mapping of salivary gland tumors: prediction of the benignancy and malignancy.

Authors:  S Eida; M Sumi; N Sakihama; H Takahashi; T Nakamura
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

Review 9.  Benign neck masses showing restricted diffusion: Is there a histological basis for discordant behavior?

Authors:  Abanti Das; Ashu S Bhalla; Raju Sharma; Atin Kumar; Meher Sharma; Shivanand Gamanagatti; Alok Thakar; Suresh Sharma
Journal:  World J Radiol       Date:  2016-02-28

10.  Non-enhanced MRI in combination with color Doppler flow imaging for improving diagnostic accuracy of parotid gland lesions.

Authors:  Wei Zhang; Zhichao Zuo; Ningbin Luo; Lianfeng Liu; Guanqiao Jin; Junjie Liu; Danke Su
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-02-12       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.